Mahmoud Aseel, Mullen Rachel, Penson Peter E, Morecroft Charles
School of Pharmacy and Biomolecular Sciences, Faculty of Science, Liverpool John Moores University, Liverpool, United Kingdom; School of Pharmacy, Isra University, Amman, Jordan.
School of Pharmacy and Biomolecular Sciences, Faculty of Science, Liverpool John Moores University, Liverpool, United Kingdom; Centre of Pharmacy Innovation, Liverpool John Moores University, Liverpool, United Kingdom.
Res Social Adm Pharm. 2021 Nov;17(11):1893-1906. doi: 10.1016/j.sapharm.2021.04.001. Epub 2021 Apr 16.
Asthma poses a public health concern, with an estimated 235 million people currently living with the condition globally. The provision of evidence-based, patient-centred services for adult asthma patients in community pharmacy which involves collaboration across the multidisciplinary team could improve their asthma control.
A literature review was conducted to examine the evidence of asthma management in community pharmacy setting.
Five databases were searched to identify relevant articles published before February 2021. Screening of the potential studies was performed to remove articles that did not comply with the inclusion criteria. Relevant data from all included studies was collected using a data extraction form to ensure consistency throughout the review.
Twenty studies were included in the review; all were conducted in community pharmacy settings in the period of 2001-2020, in different countries. The studies included randomised controlled trials, controlled trials and observational studies. Several successful community pharmacy-based services that were provided to asthma patients to improve their asthma management were highlighted in this review. These interventions consisted of one or more components and included: patient education, inhaler technique improvement, patient counselling, self-management plans, development and provision of asthma action plans and referral to other health care practitioners. None of the studies involved medication or dosage changes by community pharmacy.
The evidence discussed in this review showed that community pharmacists are well-placed to deliver services to asthma patients and many studies were conducted in the community pharmacy to improve asthma control in adult patients. However, further research could be conducted to explore further opportunities for community pharmacy to enhance asthma patients management of their condition.
哮喘引发了公共卫生问题，据估计全球目前有2.35亿人患有这种疾病。在社区药房为成年哮喘患者提供以证据为基础、以患者为中心的服务，这涉及多学科团队的协作，可改善他们的哮喘控制情况。
进行一项文献综述，以考察社区药房环境中哮喘管理的证据。
检索了五个数据库，以识别2021年2月之前发表的相关文章。对潜在研究进行筛选，以剔除不符合纳入标准的文章。使用数据提取表收集所有纳入研究的相关数据，以确保整个综述过程的一致性。
该综述纳入了20项研究；所有研究均于2001年至2020年期间在不同国家的社区药房环境中进行。这些研究包括随机对照试验、对照试验和观察性研究。本综述强调了为哮喘患者提供的几项成功的基于社区药房的服务，以改善他们的哮喘管理。这些干预措施由一个或多个部分组成，包括：患者教育、吸入技术改进、患者咨询、自我管理计划、哮喘行动计划的制定与提供以及转诊至其他医疗保健从业者。没有一项研究涉及社区药房的药物或剂量变化。
本综述中讨论的证据表明，社区药剂师很适合为哮喘患者提供服务，并且在社区药房开展了许多研究以改善成年患者的哮喘控制。然而，可以进行进一步的研究，以探索社区药房加强哮喘患者病情管理的更多机会。
